Literature DB >> 2806823

Computed tomography of the rectum with water as contrast agent.

A L Baert1, L Roex, G Wilms, G Marchal, C Deschepper.   

Abstract

The use of intrarectally administered plain tap water as a contrast medium for CT scan of the rectum and sigmoid combined with iv iodine contrast medium was prospectively studied in 28 patients. This method allowed correct demonstration of mural wall abnormalities in all patients and therefore represents a simple, inexpensive, and efficient modality for CT study of the rectum and sigmoid.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2806823     DOI： 10.1007/bf01889234

Source DB:  PubMed          Journal:  Gastrointest Radiol        ISSN： 0364-2356


  11 in total

1.  Perirectal inflammatory disease: CT findings.

Authors:  E Guillaumin; R B Jeffrey; W J Shea; C W Asling; H I Goldberg
Journal:  Radiology       Date:  1986-10       Impact factor: 11.105

2.  Local recurrence after sphincter-saving resection for rectal and rectosigmoid carcinoma. Value of various diagnostic methods.

Authors:  E Grabbe; R Winkler
Journal:  Radiology       Date:  1985-05       Impact factor: 11.105

3.  Computed tomographic air enema technique to demonstrate colonic neoplasms.

Authors:  A Solomon; M Michowitz; J Papo; I Yust
Journal:  Gastrointest Radiol       Date:  1986

4.  Management of rectal carcinoma: impact of computed tomography.

Authors:  P F van Waes; P R Koehler; M A Feldberg
Journal:  AJR Am J Roentgenol       Date:  1983-06       Impact factor: 3.959

5.  Air insufflation of the colon as an adjunct to computed tomography of the pelvis.

Authors:  A J Megibow; E A Zerhouni; D H Hulnick; E R Beranbaum; E J Balthazar
Journal:  J Comput Assist Tomogr       Date:  1984-08       Impact factor: 1.826

6.  Colorectal neoplasms: accuracy of US in demonstrating the depth of invasion.

Authors:  K Y Wang; M B Kimmey; D A Nyberg; L A Mack; R C Haggitt; W P Shuman; D W Franklin; F E Silverstein
Journal:  Radiology       Date:  1987-12       Impact factor: 11.105

7.  Perforated colorectal neoplasms: correlation of clinical, contrast enema, and CT examinations.

Authors:  D H Hulnick; A J Megibow; E J Balthazar; R B Gordon; R Surapenini; M A Bosniak
Journal:  Radiology       Date:  1987-09       Impact factor: 11.105

8.  Fat-density oral contrast agent for abdominal CT.

Authors:  V Raptopoulos; M A Davis; A Davidoff; A Karellas; D Hays; C J D'Orsi; E H Smith
Journal:  Radiology       Date:  1987-09       Impact factor: 11.105

9.  Colorectal carcinoma evaluation with CT: preoperative staging and detection of postoperative recurrence.

Authors:  P C Freeny; W M Marks; J A Ryan; J W Bolen
Journal:  Radiology       Date:  1986-02       Impact factor: 11.105

10.  Detection and staging of primary rectal and rectosigmoid cancer by computed tomography.

Authors:  R F Thoeni; A A Moss; P Schnyder; A R Margulis
Journal:  Radiology       Date:  1981-10       Impact factor: 11.105
View more
  4 in total

1.  Water as contrast medium for computed tomography study of colonic wall lesions.

Authors:  K J Gossios; E V Tsianos; D S Kontogiannis; L L Demou; C K Tatsis; V P Papakostas; M M Merkouropoulos; E C Tsimoyiannis
Journal:  Gastrointest Radiol       Date:  1992

2.  Comparison of precontrast, postcontrast, and delayed CT scanning for the staging of rectal carcinoma.

Authors:  E B Skriver; M B Nielsen; S Qvitzau; J Christiansen
Journal:  Gastrointest Radiol       Date:  1992

3.  A study on the usefulness of methylcellulose in rectal CT based on the analysis of the differences in absorption of radiation-permeable and radiation-impermeable materials.

Authors:  Jae-Hwan Cho; Hae-Kag Lee; Hyun-Ju Kim; Yeong-Cheol Heo; Jin-Hyeok Lee; In-Sik Hong
Journal:  Jpn J Radiol       Date:  2014-09-23       Impact factor: 2.374

4.  Use of contrast-enhanced post-mortem computed tomography to diagnose intestinal perforation caused by malpractice: A case report.

Authors:  Zhuoqun Wang; Kaijun Ma; Lei Wan; Donghua Zou; Ningguo Liu; Yijiu Chen
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.